Clinical Trial Details

Overview

Research Study Summary

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Purpose

Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

To Learn more

CW ID: 218099
Date Last Changed: August 25, 2016

Clinical Trial Snapshot

Phase
3
Gender
Both Male and Female
Age
18 and up
Overall Status
Recruiting
Duration
24 Weeks
Facility Type
Out-Patient

Eligibility

Eligibility Criteria:

Has been diagnosed with CRPS-I within 6 months of the time of Screening.
Has a history of a traumatic event inciting CRPS symptoms (eg, fracture, crushing injury, orthopedic surgery) within 12 months of Screening.
If receiving treatments or follow-up for CRPS-I, has been on a stable regime, except for chronic opioid therapy, for at least 3 weeks.

More Info

Treatment of pain associated with complex regional pain syndrome

Contact

Jay Dobson, Recruitment Coordinator
Northwest Clinical Research Center
1951 152nd Pl NE Suite 200
Bellevue, WA 98007
Phone: 425-453-0404
Fax: 425-453-1033

View Map

Research Center Information:

Northwest Clinical Research Center

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.